SECOND TEAM
 
Sameer Baisiwala  Morgan Stanley

Morgan Stanley’s Sameer Baisiwala wins second place honors; he’s also the No. 2 analyst in Health Care & Pharmaceuticals. Clients praise Baisiwala for his handbook, published in January 2010, on upcoming initial public offerings; the book “took the pulse of the industry,” as one money manager puts it. Baisiwala resumed coverage on Bangalore’s Sobha Developers in May 2010 with an overweight rating, at 288.15 rupees, partly on its surplus cash from new projects. The recommendation garnered mixed results, however. The stock shot to Rs392.95 in October before sliding to Rs270.50 in late May, for a loss of 6.1 percent. During the same period the sector declined 34.7 percent.